ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $909,211 | +47.3% | 29,039 | -1.9% | 0.03% | +34.8% |
| Q3 2023 | $617,072 | -5.2% | 29,610 | +9.0% | 0.02% | -4.2% |
| Q2 2023 | $650,673 | +7.2% | 27,168 | -15.8% | 0.02% | 0.0% |
| Q1 2023 | $607,076 | +147607.1% | 32,257 | +24.8% | 0.02% | +41.2% |
| Q4 2022 | $411 | -99.9% | 25,846 | -1.8% | 0.02% | -15.0% |
| Q3 2022 | $431,000 | +16.2% | 26,324 | +0.1% | 0.02% | +25.0% |
| Q2 2022 | $371,000 | -26.5% | 26,309 | +26.2% | 0.02% | -11.1% |
| Q1 2022 | $505,000 | +1.4% | 20,845 | -2.3% | 0.02% | +12.5% |
| Q4 2021 | $498,000 | +27.4% | 21,332 | -9.3% | 0.02% | +14.3% |
| Q3 2021 | $391,000 | -6.0% | 23,528 | +38.1% | 0.01% | -6.7% |
| Q2 2021 | $416,000 | +61.2% | 17,043 | +109.5% | 0.02% | -34.8% |
| Q4 2014 | $258,000 | -45.9% | 8,136 | -61.5% | 0.02% | -42.5% |
| Q2 2014 | $477,000 | -49.7% | 21,131 | -44.3% | 0.04% | -58.8% |
| Q4 2013 | $948,000 | -17.6% | 37,920 | -9.5% | 0.10% | -20.5% |
| Q3 2013 | $1,151,000 | +14.0% | 41,895 | -24.7% | 0.12% | +1.7% |
| Q2 2013 | $1,010,000 | – | 55,645 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |